Bioclinica Inactive 10-Q2008 Q1 Quarterly report

Filed: 13 May 08, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Good

New words: addressable, anniversary, applied, apply, ARB, area, arena, array, biotech, brand, Bulletin, calendar, ceased, closing, collecting, consideration, consummation, deconsolidated, deconsolidation, deferral, earlier, easier, eClinical, EDC, entity, escrow, exceed, exclusion, faster, focused, forma, framework, French, FSP, grant, hereinafter, hosting, iii, illustrative, immaterial, immateriality, indemnification, indirectly, institution, interactive, intimately, lockup, logical, merged, Merger, monitor, noncontrolling, nonfinancial, occupied, par, parent, PDS, Pennsylvania, percent, permit, permitted, Phoenix, pledge, pro, proprietary, proratably, prospectively, rapidly, registration, relevance, renewable, representational, resale, Retrospective, Revised, Roche, schedule, sell, standard, standing, stockholder, supply, surviving, Tangible, unaudited, unique, vested, voice, Worth

Removed: assessment, decreased, demonstrate, designated, documented, earning, formally, higher, larger, maturing, Nineteen, offsetting, portfolio, preparation, privately, reviewed, sort, strike, term, twelve, twenty, withheld, withholding

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Bioclinica similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Bio-Imaging Technologies, Inc. (the “Company”) for the quarter ended September 30, 2007 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Ted I. Kaminer, Senior Vice President and Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Bio-Imaging Technologies, Inc.



Dated: May 13, 2008	/s/ Ted I. Kaminer*
	Ted I. Kaminer, Senior Vice President and Chief
	Financial Officer (Principal Financial and Accounting Officer)


*		A signed original of this written statement required by Section 906 has been provided to us and will be retained by us and furnished to the Securities and Exchange Commission or its staff upon request.